Controversies in the pathophysiology of leg ulcers in sickle cell disease
- PMID: 38867511
- DOI: 10.1111/bjh.19584
Controversies in the pathophysiology of leg ulcers in sickle cell disease
Abstract
Patients with sickle cell disease (SCD) often experience painful vaso-occlusive crises and chronic haemolytic anaemia, as well as various acute and chronic complications, such as leg ulcers. Leg ulcers are characterized by their unpredictability, debilitating pain and prolonged healing process. The pathophysiology of SCD leg ulcers is not well defined. Known risk factors include male gender, poor social conditions, malnutrition and a lack of compression therapy when oedema occurs. Leg ulcers typically start with spontaneous pain, followed by induration, hyperpigmentation, blister formation and destruction of the epidermis. SCD is characterized by chronic haemolysis, increased oxidative stress and decreased nitric oxide bioavailability, which promote ischaemia and inflammation and consequently impair vascular function in the skin. This cutaneous vasculopathy, coupled with venostasis around the ankle, creates an ideal environment for local vaso-occlusive crises, which can result in the development of leg ulcers that resemble arterial ulcers. Following the development of the ulcer, healing is hindered as a result of factors commonly observed in venous ulceration, including venous insufficiency, oedema and impaired angiogenesis. All of these factors are modulated by genetic factors. However, our current understanding of these genetic factors remains limited and does not yet enable us to accurately predict ulceration susceptibility.
Keywords: chronic wounds; leg ulcers; pathophysiology; sickle cell disease; treatment.
© 2024 The Author(s). British Journal of Haematology published by British Society for Haematology and John Wiley & Sons Ltd.
Similar articles
-
Abnormal venous function in patients with homozygous sickle cell (SS) disease and chronic leg ulcers.Clin Sci (Lond). 2000 Jun;98(6):667-72. Clin Sci (Lond). 2000. PMID: 10814603
-
Vasculopathy, inflammation, and blood flow in leg ulcers of patients with sickle cell anemia.Am J Hematol. 2014 Jan;89(1):1-6. doi: 10.1002/ajh.23571. Epub 2013 Sep 19. Am J Hematol. 2014. PMID: 23963836 Free PMC article.
-
Common, But Neglected: A Comprehensive Review of Leg Ulcers in Sickle Cell Disease.Adv Skin Wound Care. 2021 Aug 1;34(8):423-431. doi: 10.1097/01.ASW.0000755924.12513.40. Adv Skin Wound Care. 2021. PMID: 34260420 Review.
-
Sickle cell leg ulcers: associations with haemolysis and SNPs in Klotho, TEK and genes of the TGF-beta/BMP pathway.Br J Haematol. 2006 Jun;133(5):570-8. doi: 10.1111/j.1365-2141.2006.06074.x. Br J Haematol. 2006. PMID: 16681647 Free PMC article.
-
A treatment algorithm to identify therapeutic approaches for leg ulcers in patients with sickle cell disease.Int Wound J. 2016 Dec;13(6):1315-1324. doi: 10.1111/iwj.12522. Epub 2015 Nov 4. Int Wound J. 2016. PMID: 26537664 Free PMC article. Review.
Cited by
-
Impaired microvascular function in patients with sickle cell anemia and leg ulcers improved with healing.Br J Haematol. 2024 Dec;205(6):2459-2469. doi: 10.1111/bjh.19785. Epub 2024 Sep 24. Br J Haematol. 2024. PMID: 39318045 Free PMC article.
References
REFERENCES
-
- Rees DC, Williams TN, Gladwin MT. Sickle‐cell disease. Lancet. 2010;376(9757):2018–2031.
-
- Therrell BL, Lloyd‐Puryear MA, Eckman JR, Mann MY. Newborn screening for sickle cell diseases in the United States: a review of data spanning 2 decades. Semin Perinatol. 2015;39(3):238–251.
-
- Pauling L, Itano HA. Sickle cell anemia a molecular disease. Science. 1949;110(2865):543–548.
-
- Kato GJ, Piel FB, Reid CD, Gaston MH, Ohene‐Frempong K, Krishnamurti L, et al. Sickle cell disease. Nat Rev Dis Primers. 2018;4(1):1–22.
-
- Serjeant GR. Leg ulceration in sickle cell anemia. Arch Intern Med. 1974;133(4):690–694.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical